Search returned 674 results
Hamster Hybridoma producing Monoclonal Antibody against Mouse CXCL9Sheehan, Kathleen ; Schreiber, Robert
T-005944
— Target: Inflammatory chemokine CXCL9, monokine induced by IFN-gamma. Secreted mainly by macrophages. Notes: Clone MIG-2F5-5. Use in ELISA, neutralizing and binding assays.
Murine Hybridoma producing IgG1 Monoclonal Antibody to Human CD158iColonna, Marco
T-005376
— Target: A member of the killer immunoglobulin-like receptor (KIR) family expressed on natural killer cells. Notes: Clone JJC116
Murine Hybridoma producing IgG1 Monoclonal Antibody to Human NKp30Colonna, Marco
T-005378
— Target: NKp30 (aka CD337) is an natural killer cell receptor. Notes: Clone name is AF29-4D12.
Murine Hybridoma producing IgG1 Monoclonal Antibody to Human CD226 (DNAM-1)Colonna, Marco
T-005408
— Target: CD226 is a glycoprotein expressed on natural killer cells, platlets, monocytes and a subset of T cells. Notes: Clone name is 11A8, used for flow cytometry.
Murine Hybridoma producing IgG1 Monoclonal Antibody to Human CD155Colonna, Marco
T-005410
— Target: Cluster of Differentiation 155 protein, a.k.a. Poliovirus Receptor. Notes: Clone name is SKII.4.
Murine Hybridoma producing IgG1 Monoclonal Antibody to Human SIRP Alpha + BetaColonna, Marco
T-005413
— Target: Cluster of Differentiation 172g protein, a.k.a. Signal Regulatory Protein Alpha and Beta. Notes: Clone name is 148.
Murine Hybridoma producing IgG2a Monoclonal Antibody to Mouse Rae1 DeltaColonna, Marco
T-005805
— Target: Retinoic Acid Early 1 Delta protein. Notes: Clone Charlotte O1.23.
Murine Hybridoma producing IgG1 Monoclonal Antibody to Human B7-H3Colonna, Marco
T-007604
— Target: Cluster of Differentiation, a.k.a. Neural Cell Adhesion Molecule. Notes: Clone name is DCN.70.
Rat Hybridoma producing IgG2b mAB to Mouse Natural IPC-Specific AntigenColonna, Marco
T-005806
— Target: Natural Interferon-Producing Cell-Specific Antigen Notes: Clone available is 440c
Venezuelan Equine Encephalitis Virus (VEEV) AntibodiesDiamond, Michael
T-015386
— Primary Inventor: Michael S. Diamond, MD Target: Venezuelan Equine Encephalitis Virus
Anti-prM Monoclonal Antibody against all four Dengue Virus SerotypesDiamond, Michael
T-015814
— Target: Dengue Virus Notes: PrM-12 and -22
Recombinant Chikungunya Virus Soluble E2 ProteinDiamond, Michael ; Pal, Pankaj ; Barrow, Melissa ; Fremont, Daved
T-014734 Knockout Mouse lacking Expression of the Batf3 Gene
Schreiber, Robert ; Unanue, Emil ; Diamond, Michael ; Murphy, Theresa ; Murphy, Kenneth
T-009136
— Notes: Batf3-/- knockout mouse with a 129SvEv background.
Niemann Pick Type C (NPC) Mouse ModelOry, Daniel
T-012764
— Notes: Mouse model with the mutation for NPC knocked in.
B6.129.Btla tm1kmm/J MouseMurphy, Theresa ; Murphy, Kenneth
T-014100
— Notes: Btla-/- knockout mouse with a 129S/SvEv background. B6.129.Btla tm1kmm/J Mouse.
Whole Body Knockout Mouse on CISD2 GeneUrano, Fumihiko
T-017431 Conditional Lama5 Mutant Mice
Miner, Jeffrey
T-017526 Nanomaterials for Imaging and Treatment of Amyloidosis
Liu, Yongjian ; Bieschke, Jan ; Guruswami, Sundaram ; Sharma, Vijay
T-017876
— Background 8 million people per year are diagnosed with light-chain (AL) amyloidosis, a progressive disease than can quickly affect the kidney, heart, and nervous system if left untreated. The current method of diagnosis involves histological confirmation via biopsies of bone marrow, fat, and organ…
Design and Development of Organomedicinals for Imaging and Treatment of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia (FTD)Sivapackiam, Jothilingam ; Guruswami, Sundaram ; Sharma, Vijay
T-016665
— Background Frontotemporal Dementia (FTD) is the second most common form of non-Alzheimer’s dementia in the population under 65 years old. FTD represents approximately 20% of all dementias and onset normally appears in the mid to late 50s. Clinically FTD is characterized by a progressive neur…
High Affinity Mannose Receptor LigandStahl, Philip
T-000197
— Technology Description: The mannose receptor is uniquely found on macrophages and not on monocytes, making the mannose receptor a target for macrophage activation. Researchers at Washington University have developed polypeptide backbones to target the mannose receptor on macrophages. This technology…
